{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T05:12:59Z","timestamp":1780549979861,"version":"3.54.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T00:00:00Z","timestamp":1669334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T00:00:00Z","timestamp":1669334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 32071128"],"award-info":[{"award-number":["No. 32071128"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 32071128"],"award-info":[{"award-number":["No. 32071128"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 32071128"],"award-info":[{"award-number":["No. 32071128"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 32071128"],"award-info":[{"award-number":["No. 32071128"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 32071128"],"award-info":[{"award-number":["No. 32071128"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2023,1,20]]},"DOI":"10.1038\/s41388-022-02549-7","type":"journal-article","created":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T16:32:27Z","timestamp":1669393947000},"page":"308-321","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Imbalance in ALR ubiquitination accelerates the progression of nonalcoholic steatohepatitis to hepatocellular carcinoma"],"prefix":"10.1038","volume":"42","author":[{"given":"Mingzhe","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwei","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9648-4497","authenticated-orcid":false,"given":"Wei","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,25]]},"reference":[{"key":"2549_CR1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69\u201390.","journal-title":"CA Cancer J Clin"},{"key":"2549_CR2","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/hep.28123","volume":"62","author":"ZM Younossi","year":"2015","unstructured":"Younossi ZM, Otgonsuren M, Henry L, Venkatesan C, Mishra A, Erario M, et al. Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009. Hepatology. 2015;62:1723\u201330.","journal-title":"Hepatology"},{"key":"2549_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1872-034X.2011.00872.x","volume":"42","author":"E Hashimoto","year":"2012","unstructured":"Hashimoto E, Tokushige K. Hepatocellular carcinoma in non-alcoholic steatohepatitis: Growing evidence of an epidemic? Hepatol Res. 2012;42:1\u201314.","journal-title":"Hepatol Res"},{"key":"2549_CR4","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3322\/caac.21499","volume":"69","author":"H Sung","year":"2019","unstructured":"Sung H, Siegel RL, Torre LA, Pearson-Stuttard J, Islami F, Fedewa SA, et al. Global patterns in excess body weight and the associated cancer burden. CA Cancer J Clin. 2019;69:88\u2013112.","journal-title":"CA Cancer J Clin"},{"key":"2549_CR5","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.jhep.2011.10.027","volume":"56","author":"G Baffy","year":"2012","unstructured":"Baffy G, Brunt EM, Caldwell SH. Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. J Hepatol. 2012;56:1384\u201391.","journal-title":"J Hepatol"},{"key":"2549_CR6","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67:328\u201357.","journal-title":"Hepatology"},{"key":"2549_CR7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cell.2009.12.052","volume":"140","author":"EJ Park","year":"2010","unstructured":"Park EJ, Lee JH, Yu GY, He G, Ali SR, Holzer RG, et al. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell. 2010;140:197\u2013208.","journal-title":"Cell"},{"key":"2549_CR8","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1053\/j.gastro.2006.05.054","volume":"131","author":"H Tilg","year":"2006","unstructured":"Tilg H, Hotamisligil GS. Nonalcoholic fatty liver disease: Cytokine-adipokine interplay and regulation of insulin resistance. Gastroenterology. 2006;131:934\u201345.","journal-title":"Gastroenterology."},{"key":"2549_CR9","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ccr.2014.07.001","volume":"26","author":"H Nakagawa","year":"2014","unstructured":"Nakagawa H, Umemura A, Taniguchi K, Font-Burgada J, Dhar D, Ogata H, et al. ER stress cooperates with hypernutrition to trigger TNF-dependent spontaneous HCC development. Cancer Cell. 2014;26:331\u201343.","journal-title":"Cancer Cell"},{"key":"2549_CR10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nature12347","volume":"499","author":"S Yoshimoto","year":"2013","unstructured":"Yoshimoto S, Loo TM, Atarashi K, Kanda H, Sato S, Oyadomari S, et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature. 2013;499:97\u2013101.","journal-title":"Nature"},{"key":"2549_CR11","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.4254\/wjh.v7.i17.2110","volume":"7","author":"H Nakagawa","year":"2015","unstructured":"Nakagawa H. Recent advances in mouse models of obesity- and nonalcoholic steatohepatitis-associated hepatocarcinogenesis. World J Hepatol. 2015;7:2110\u201318.","journal-title":"World J Hepatol"},{"key":"2549_CR12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1113\/jphysiol.1975.sp010973","volume":"248","author":"DR LaBrecque","year":"1975","unstructured":"LaBrecque DR, Pesch LA. Preparation and partial characterization of hepatic regenerative stimulator substance (SS) from rat liver. J Physiol. 1975;248:273\u201384.","journal-title":"J Physiol"},{"key":"2549_CR13","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/hep.1840170418","volume":"17","author":"MH Mei","year":"1993","unstructured":"Mei MH, An W, Zhang BH, Shao Q, Gong DZ. Hepatic stimulator substance protects against acute liver failure induced by carbon tetrachloride poisoning in mice. Hepatology. 1993;17:638\u201344.","journal-title":"Hepatology"},{"key":"2549_CR14","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1136\/gut.50.6.869","volume":"50","author":"DW Ho","year":"2002","unstructured":"Ho DW, Fan ST, To J, Woo YH, Zhang Z, Lau C, et al. Selective plasma filtration for treatment of fulminant hepatic failure induced by D-galactosamine in a pig model. Gut. 2002;50:869\u201376.","journal-title":"Gut"},{"key":"2549_CR15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.abb.2007.03.025","volume":"464","author":"Y Wu","year":"2007","unstructured":"Wu Y, Chen L, Yu H, Liu H, An W. Transfection of hepatic stimulator substance gene desensitizes hepatoma cells to H2O2-induced cell apoptosis via preservation of mitochondria. Arch Biochem Biophysics. 2007;464:48\u201356.","journal-title":"Arch Biochem Biophysics"},{"key":"2549_CR16","first-page":"887","volume":"7","author":"HY Yu","year":"2014","unstructured":"Yu HY, Zhu MH, Xiang DR, Li J, Sheng JF. High expression of 23 kDa protein of augmenter of liver regeneration (ALR) in human hepatocellular carcinoma. Onco Targets Ther. 2014;7:887\u201393.","journal-title":"Onco Targets Ther"},{"key":"2549_CR17","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.freeradbiomed.2009.07.017","volume":"47","author":"Y Cao","year":"2009","unstructured":"Cao Y, Fu YL, Yu M, Yue PB, Ge CH, Xu WX, et al. Human augmenter of liver regeneration is important for hepatoma cell viability and resistance to radiation-induced oxidative stress. Free Radic Biol Med. 2009;47:1057\u201366.","journal-title":"Free Radic Biol Med"},{"key":"2549_CR18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2559.2005.02172.x","volume":"47","author":"WE Thasler","year":"2005","unstructured":"Thasler WE, Schlott T, Thelen P, Hellerbrand C, Bataille F, Lichtenauer M, et al. Expression of augmenter of liver regeneration (ALR) in human liver cirrhosis and carcinoma. Histopathology. 2005;47:57\u201366.","journal-title":"Histopathology"},{"key":"2549_CR19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2119\/molmed.2010.00117","volume":"17","author":"R Dayoub","year":"2011","unstructured":"Dayoub R, Wagner H, Bataille F, St\u00f6ltzing O, Spruss T, Buechler C, et al. Liver regeneration associated protein (ALR) exhibits antimetastatic potential in hepatocellular carcinoma. Mol Med (Camb, Mass). 2011;17:221\u201328.","journal-title":"Mol Med (Camb, Mass)"},{"key":"2549_CR20","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1053\/j.gastro.2014.10.008","volume":"148","author":"CR Gandhi","year":"2015","unstructured":"Gandhi CR, Chaillet JR, Nalesnik MA, Kumar S, Dangi A, Demetris AJ, et al. Liver-specific deletion of augmenter of liver regeneration accelerates development of steatohepatitis and hepatocellular carcinoma in mice. Gastroenterology. 2015;148:379\u201391.","journal-title":"Gastroenterology"},{"key":"2549_CR21","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.cell.2019.04.010","volume":"177","author":"MI Hern\u00e1ndez-Alvarez","year":"2019","unstructured":"Hern\u00e1ndez-Alvarez MI, Sebasti\u00e1n D, Vives S, Ivanova S, Bartoccioni P, Kakimoto P, et al. Deficient endoplasmic reticulum-mitochondrial phosphatidylserine transfer causes liver disease. Cell. 2019;177:881\u201395.","journal-title":"Cell"},{"key":"2549_CR22","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1136\/gutjnl-2017-315193","volume":"67","author":"N Fujiwara","year":"2018","unstructured":"Fujiwara N, Nakagawa H, Enooku K, Kudo Y, Hayata Y, Nakatsuka T, et al. CPT2 downregulation adapts HCC to lipid-rich environment and promotes carcinogenesis via acylcarnitine accumulation in obesity. Gut. 2018;67:1493\u2013504.","journal-title":"Gut"},{"key":"2549_CR23","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jhep.2018.03.011","volume":"69","author":"T Tsuchida","year":"2018","unstructured":"Tsuchida T, Lee YA, Fujiwara N, Ybanez M, Allen B, Martins S, et al. A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer. J Hepatol. 2018;69:385\u201395.","journal-title":"J Hepatol"},{"key":"2549_CR24","volume":"8","author":"Y Li","year":"2017","unstructured":"Li Y, Xie P, Lu L, Wang J, Diao L, Liu Z, et al. An integrated bioinformatics platform for investigating the human E3 ubiquitin ligase-substrate interaction network. Nat Commun. 2017;8:347.","journal-title":"Nat Commun"},{"key":"2549_CR25","doi-asserted-by":"crossref","first-page":"D719","DOI":"10.1093\/nar\/gkab962","volume":"50","author":"X Wang","year":"2022","unstructured":"Wang X, Li Y, He M, Kong X, Jiang P, Liu X, et al. UbiBrowser 2.0: a comprehensive resource for proteome-wide known and predicted ubiquitin ligase\/deubiquitinase-substrate interactions in eukaryotic species. Nucleic Acids Res. 2022;50:D719\u201328.","journal-title":"Nucleic Acids Res"},{"key":"2549_CR26","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/sj.embor.7401062","volume":"8","author":"JT Cribbs","year":"2007","unstructured":"Cribbs JT, Strack S. Reversible phosphorylation of Drp1 by cyclic AMP-dependent protein kinase and calcineurin regulates mitochondrial fission and cell death. EMBO Rep. 2007;8:939\u201344.","journal-title":"EMBO Rep"},{"key":"2549_CR27","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","volume":"67","author":"C Estes","year":"2018","unstructured":"Estes C, Razavi H, Loomba R, Younossi Z, Sanyal AJ. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology. 2018;67:123\u201333.","journal-title":"Hepatology"},{"key":"2549_CR28","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","volume":"18","author":"DQ Huang","year":"2021","unstructured":"Huang DQ, El-Serag HB, Loomba R. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2021;18:223\u201338.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2549_CR29","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/s41374-018-0039-2","volume":"98","author":"X Jia","year":"2018","unstructured":"Jia X, Li Z, Dong L, Sun G, Wang X, Gao J, et al. Lack of hepatic stimulator substance expression promotes hepatocellular carcinoma metastasis partly through ERK-activated epithelial-mesenchymal transition. Lab Investig J Tech Methods Pathol. 2018;98:871\u201382.","journal-title":"Lab Investig J Tech Methods Pathol"},{"key":"2549_CR30","doi-asserted-by":"crossref","first-page":"12637","DOI":"10.18632\/oncotarget.14478","volume":"8","author":"H Shi","year":"2017","unstructured":"Shi H, Han W, Shi H, Ren F, Chen D, Chen Y. et al. Augmenter of liver regeneration protects against carbon tetrachloride-induced liver injury by promoting autophagy in mice. Oncotarget. 2017;8:12637\u201348.","journal-title":"Oncotarget"},{"key":"2549_CR31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3892\/etm.2013.1140","volume":"7","author":"N Wang","year":"2014","unstructured":"Wang N, Sun H, Tang L, Deng J, Luo Y, Guo H, et al. Establishment and primary clinical application of competitive inhibition for measurement of augmenter of liver regeneration. Exp Therapeutic Med. 2014;7:93\u20136.","journal-title":"Exp Therapeutic Med"},{"key":"2549_CR32","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/hep.29047","volume":"66","author":"MA Nalesnik","year":"2017","unstructured":"Nalesnik MA, Gandhi CR, Starzl TE. Augmenter of liver regeneration: A fundamental life protein. Hepatology. 2017;66:266\u201370.","journal-title":"Hepatology"},{"key":"2549_CR33","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0968-0004(97)01119-5","volume":"22","author":"DP Lane","year":"1997","unstructured":"Lane DP, Hall PA. MDM2\u2013arbiter of p53\u2019s destruction. Trends Biochem Sci. 1997;22:372\u201374.","journal-title":"Trends Biochem Sci"},{"key":"2549_CR34","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/jcb.22940","volume":"112","author":"MS Kim","year":"2011","unstructured":"Kim MS, Ramakrishna S, Lim KH, Kim JH, Baek KH. Protein stability of mitochondrial superoxide dismutase SOD2 is regulated by USP36. J Cell Biochem. 2011;112:498\u2013508.","journal-title":"J Cell Biochem"},{"key":"2549_CR35","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/hep.26226","volume":"58","author":"K Begriche","year":"2013","unstructured":"Begriche K, Massart J, Robin MA, Bonnet F, Fromenty B. Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease. Hepatology. 2013;58:1497\u2013507.","journal-title":"Hepatology"},{"key":"2549_CR36","doi-asserted-by":"crossref","first-page":"G632","DOI":"10.1152\/ajpgi.00182.2014","volume":"307","author":"CA Galloway","year":"2014","unstructured":"Galloway CA, Lee H, Brookes PS, Yoon Y. Decreasing mitochondrial fission alleviates hepatic steatosis in a murine model of nonalcoholic fatty liver disease. Am J Physiol Gastrointest Liver Physiol. 2014;307:G632\u201341.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2549_CR37","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.7150\/thno.21400","volume":"7","author":"J Du","year":"2017","unstructured":"Du J, Zhang X, Han J, Man K, Zhang Y, Chu ES, et al. Pro-Inflammatory CXCR3 Impairs Mitochondrial Function in Experimental Non-Alcoholic Steatohepatitis. Theranostics. 2017;7:4192\u2013203.","journal-title":"Theranostics"},{"key":"2549_CR38","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1056\/NEJMra1215233","volume":"369","author":"SL Archer","year":"2013","unstructured":"Archer SL. Mitochondrial dynamics\u2013mitochondrial fission and fusion in human diseases. N. Engl J Med. 2013;369:2236\u201351.","journal-title":"N. Engl J Med"},{"key":"2549_CR39","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1053\/j.gastro.2018.06.083","volume":"155","author":"A Mansouri","year":"2018","unstructured":"Mansouri A, Gattolliat CH, Asselah T. Mitochondrial dysfunction and signaling in chronic liver diseases. Gastroenterology. 2018;155:629\u201347.","journal-title":"Gastroenterology"},{"key":"2549_CR40","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S1534-5807(01)00055-7","volume":"1","author":"S Frank","year":"2001","unstructured":"Frank S, Gaume B, Bergmann-Leitner ES, Leitner WW, Robert EG, Catez F, et al. The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis. Dev Cell. 2001;1:515\u201325.","journal-title":"Dev Cell"},{"key":"2549_CR41","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1002\/hep.29326","volume":"66","author":"C Zhang","year":"2017","unstructured":"Zhang C, Huang J, An W. Hepatic stimulator substance resists hepatic ischemia\/reperfusion injury by regulating Drp1 translocation and activation. Hepatology. 2017;66:1989\u20132001.","journal-title":"Hepatology"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02549-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02549-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02549-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T03:57:05Z","timestamp":1710907025000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02549-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,25]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,1,20]]}},"alternative-id":["2549"],"URL":"https:\/\/doi.org\/10.1038\/s41388-022-02549-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1784603\/v1","asserted-by":"object"}]},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,25]]},"assertion":[{"value":"22 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Capital Medical University Ethics Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}